Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
BABaxter International Inc. logo

Baxter International Inc. (BAX)

New York Stock Exchange · Currency in USD
$25.30 ▼ -0.35 (-1.36%)
At close: Oct 23, 4:00 PM ET. Market closed.
$25.30 ▲ +0.00 (+0.00%)
After hours: Oct 23, 5:42 PM ET

Summary

Previous Close
$25.65
Open
$25.56
Day's Range
$25.20 – $25.70
52 Week Range
$15.73 – $30.00
Volume
4,936,022
Avg. Volume
6,501,982
Market Cap
$13.08B
Beta (5Y Monthly)
0.65
PE Ratio (TTM)
--
EPS (TTM)
-$2.06
Earnings Date
Oct 29, 2026
Forward Dividend & Yield
$0.04 (0.16%)
Ex-Dividend Date
Aug 28, 2026
1y Target Est
$23.60

Profile: Baxter International Inc.

Sector
Healthcare
Industry
Medical - Instruments & Supplies
Full-time employees
37,500
CEO
Andrew Hider
Website
baxter.com

Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug reconstitution.

Earnings

Next report: Thu, Oct 29, 2026
EPS estimate $0.52 · Revenue est. $2.91B
DateEst.Actual
Jul 30, 2026$0.37$0.56Beat
Apr 30, 2026$0.31$0.36Beat
Feb 12, 2026$0.53$0.44Miss
Oct 30, 2025$0.60$0.69Beat
Jul 31, 2025$0.60$0.59Miss
May 1, 2025$0.48$0.55Beat

Analyst view

Consensus price target
$23.60 ▼ -6.7%
Range $20.00 – $28.00
Rating: Hold
Buy 42% · Hold 56% · Sell 3%

Get free alerts on BAX and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.